Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Biosynthesis of Cannabinoids Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosynthesis of Cannabinoids Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosynthesis of Cannabinoids Overall Market Size
2.1 Global Biosynthesis of Cannabinoids Market Size: 2022 VS 2028
2.2 Global Biosynthesis of Cannabinoids Market Size, Prospects & Forecasts: 2022-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key Biosynthesis of Cannabinoids Players in Global Market
3.2 Global Companies Biosynthesis of Cannabinoids Product & Technology
4 Players Profiles
4.1 Anandia Laboratories
4.1.1 Anandia Laboratories Corporate Summary
4.1.2 Anandia Laboratories Business Overview
4.1.3 Anandia Laboratories Biosynthesis of Cannabinoids Product Offerings & Technology
4.1.4 Anandia Laboratories Biosynthesis of Cannabinoids R&D, and Plans
4.2 Gingko Bioworks
4.2.1 Gingko Bioworks Corporate Summary
4.2.2 Gingko Bioworks Business Overview
4.2.3 Gingko Bioworks Biosynthesis of Cannabinoids Product Offerings & Technology
4.2.4 Gingko Bioworks Biosynthesis of Cannabinoids R&D, and Plans
4.3 Hyasynth Bio
4.3.1 Hyasynth Bio Corporate Summary
4.3.2 Hyasynth Bio Business Overview
4.3.3 Hyasynth Bio Biosynthesis of Cannabinoids Product Offerings & Technology
4.3.4 Hyasynth Bio Biosynthesis of Cannabinoids R&D, and Plans
4.4 InMed Pharmaceuticals
4.4.1 InMed Pharmaceuticals Corporate Summary
4.4.2 InMed Pharmaceuticals Business Overview
4.4.3 InMed Pharmaceuticals Biosynthesis of Cannabinoids Product Offerings & Technology
4.4.4 InMed Pharmaceuticals Biosynthesis of Cannabinoids R&D, and Plans
4.5 Librede
4.5.1 Librede Corporate Summary
4.5.2 Librede Business Overview
4.5.3 Librede Biosynthesis of Cannabinoids Product Offerings & Technology
4.5.4 Librede Biosynthesis of Cannabinoids R&D, and Plans
4.6 Renew Biopharma
4.6.1 Renew Biopharma Corporate Summary
4.6.2 Renew Biopharma Business Overview
4.6.3 Renew Biopharma Biosynthesis of Cannabinoids Product Offerings & Technology
4.6.4 Renew Biopharma Biosynthesis of Cannabinoids R&D, and Plans
4.7 Cronos Group
4.7.1 Cronos Group Corporate Summary
4.7.2 Cronos Group Business Overview
4.7.3 Cronos Group Biosynthesis of Cannabinoids Product Offerings & Technology
4.7.4 Cronos Group Biosynthesis of Cannabinoids R&D, and Plans
4.8 Organigram
4.8.1 Organigram Corporate Summary
4.8.2 Organigram Business Overview
4.8.3 Organigram Biosynthesis of Cannabinoids Product Offerings & Technology
4.8.4 Organigram Biosynthesis of Cannabinoids R&D, and Plans
4.9 Teewinot Life Sciences
4.9.1 Teewinot Life Sciences Corporate Summary
4.9.2 Teewinot Life Sciences Business Overview
4.9.3 Teewinot Life Sciences Biosynthesis of Cannabinoids Product Offerings & Technology
4.9.4 Teewinot Life Sciences Biosynthesis of Cannabinoids R&D, and Plans
4.10 ICC International Cannabis Corp.
4.10.1 ICC International Cannabis Corp. Corporate Summary
4.10.2 ICC International Cannabis Corp. Business Overview
4.10.3 ICC International Cannabis Corp. Biosynthesis of Cannabinoids Product Offerings & Technology
4.10.4 ICC International Cannabis Corp. Biosynthesis of Cannabinoids R&D, and Plans
4.11 Biotii Technologies Corp.
4.11.1 Biotii Technologies Corp. Corporate Summary
4.11.2 Biotii Technologies Corp. Business Overview
4.11.3 Biotii Technologies Corp. Biosynthesis of Cannabinoids Product Offerings & Technology
4.11.4 Biotii Technologies Corp. Biosynthesis of Cannabinoids R&D, and Plans
4.12 Bristol-Myers Squibb
4.12.1 Bristol-Myers Squibb Corporate Summary
4.12.2 Bristol-Myers Squibb Business Overview
4.12.3 Bristol-Myers Squibb Biosynthesis of Cannabinoids Product Offerings & Technology
4.12.4 Bristol-Myers Squibb Biosynthesis of Cannabinoids R&D, and Plans
4.13 Biogen Inc.
4.13.1 Biogen Inc. Corporate Summary
4.13.2 Biogen Inc. Business Overview
4.13.3 Biogen Inc. Biosynthesis of Cannabinoids Product Offerings & Technology
4.13.4 Biogen Inc. Biosynthesis of Cannabinoids R&D, and Plans
4.14 GW Pharmaceuticals
4.14.1 GW Pharmaceuticals Corporate Summary
4.14.2 GW Pharmaceuticals Business Overview
4.14.3 GW Pharmaceuticals Biosynthesis of Cannabinoids Product Offerings & Technology
4.14.4 GW Pharmaceuticals Biosynthesis of Cannabinoids R&D, and Plans
5 Sights by Region
5.1 By Region - Global Biosynthesis of Cannabinoids Market Size, 2023 & 2028
5.2 By Region - Global Biosynthesis of Cannabinoids Revenue, (2023-2028)
5.3 United States
5.3.1 Key Players of Biosynthesis of Cannabinoids in United States
5.3.2 United States Biosynthesis of Cannabinoids Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of Biosynthesis of Cannabinoids in Europe
5.4.2 Europe Biosynthesis of Cannabinoids Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of Biosynthesis of Cannabinoids in China
5.5.2 China Biosynthesis of Cannabinoids Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 by Type - Global Biosynthesis of Cannabinoids Market Size Markets, 2023 & 2028
6.2 THC
6.3 CBD
6.4 Others
7 Sights by Application
7.1 By Application - Global Biosynthesis of Cannabinoids Market Size, 2023 & 2028
7.2 Food Industry
7.3 Medical Industry
7.4 Others
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer